ABVC BioPharma Inc (ABVC)
0.5306
0.00 (0.00%)
USD |
NASDAQ |
Nov 14, 12:29
ABVC BioPharma Total Assets (Quarterly): 14.63M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 14.63M |
| March 31, 2024 | 14.46M |
| December 31, 2023 | 14.49M |
| September 30, 2023 | 16.59M |
| June 30, 2023 | 9.320M |
| March 31, 2023 | 10.73M |
| December 31, 2022 | 9.580M |
| September 30, 2022 | 10.48M |
| June 30, 2022 | 13.78M |
| March 31, 2022 | 12.07M |
| December 31, 2021 | 13.70M |
| September 30, 2021 | 12.35M |
| June 30, 2021 | 8.945M |
| March 31, 2021 | 10.53M |
| December 31, 2020 | 11.61M |
| September 30, 2020 | 6.529M |
| June 30, 2020 | 6.432M |
| March 31, 2020 | 6.665M |
| December 31, 2019 | 6.928M |
| September 30, 2019 | 7.405M |
| June 30, 2019 | 7.140M |
| March 31, 2019 | 7.450M |
| December 31, 2018 | 0.0963M |
| September 30, 2018 | 2.594M |
| June 30, 2018 | 2.650M |
| Date | Value |
|---|---|
| March 31, 2018 | 2.556M |
| December 31, 2017 | 2.643M |
| September 30, 2017 | 2.755M |
| June 30, 2017 | 0.0081M |
| March 31, 2017 | 0.1064M |
| December 31, 2016 | 0.0186M |
| September 30, 2016 | 0.1774M |
| June 30, 2016 | 3.589M |
| March 31, 2016 | 0.8765M |
| December 31, 2015 | 0.0649M |
| September 30, 2015 | 1.002M |
| June 30, 2015 | 0.0673M |
| March 31, 2015 | 0.0646M |
| December 31, 2014 | 0.0646M |
| September 30, 2014 | 0.0654M |
| June 30, 2014 | 0.2319M |
| March 31, 2014 | 0.2319M |
| December 31, 2013 | 0.232M |
| September 30, 2013 | 0.232M |
| June 30, 2013 | 0.232M |
| March 31, 2013 | 0.2513M |
| December 31, 2012 | 0.2718M |
| September 30, 2012 | 0.3023M |
| June 30, 2012 | 0.3777M |
| March 31, 2012 | 0.2906M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
6.432M
Minimum
Jun 2020
16.59M
Maximum
Sep 2023
11.04M
Average
10.73M
Median
Mar 2023
Total Assets (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 3.925M |
| Palatin Technologies Inc | 10.74M |
| iBio Inc | 28.73M |
| Theriva Biologics Inc | 42.39M |
| Oragenics Inc | 2.710M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 6.805M |
| Shareholders Equity (Quarterly) | 8.294M |
| Debt to Equity Ratio | 0.2175 |
| Current Ratio | 0.3343 |
| Net Debt Paydown Yield | 4.94% |